Wikipedia
Phagoburn
Phagoburn is a current European Union financed clinical study focused on testing the medical uses of bacteriophage for treating wounds. The main objective of Phagoburn is to assess the safety, effectiveness and pharmacodynamics of two therapeutic phage cocktails to treat E. coli and P. aeruginosa burn wound infections. It is taking place in France, Belgium, and Switzerland. Pherecydes Pharma is the main sponsor of the trial.